HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1801	23858 Crews L, Tsigelny I, Hashimoto M, Masliah E Role of Synucleins in Alzheimer's Disease NEUROTOXICITY RESEARCH. 2009 OCT; 16 (3): 306-317	5	7	87	151
1802	24209 Bousman CA, Glatt SJ, Everall IP, Tsuang MT Genetic Association Studies of Methamphetamine Use Disorders: A Systematic Review and Synthesis AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS. 2009 DEC 5; 150B (8): 1025-1049	0	2	8	151
1803	25516 Johansen KK, White LR, Sando SB, Aasly JO Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies PARKINSONISM & RELATED DISORDERS. 2010 JUN; 16 (5): 307-315	1	1	71	151
1804	26285 Greenwald J, Riek R Biology of Amyloid: Structure, Function, and Regulation STRUCTURE. 2010 OCT 13; 18 (10): 1244-1260	0	0	11	151
1805	26559 Antonelli F, Ray N, Strafella AP Imaging cognitive and behavioral symptoms in Parkinson's disease EXPERT REVIEW OF NEUROTHERAPEUTICS. 2010 DEC; 10 (12): 1827-1838	0	0	19	151
1806	4952 Plassman BL, Breitner JCS The genetics of dementia in late life PSYCHIATRIC CLINICS OF NORTH AMERICA. 1997 MAR; 20 (1): 59-&	1	9	2	150
1807	6313 Hauw JJ, Seilhean D, Colle MA, Hogenhuys J, Duyckaerts G Neuropathological markers of degenerative dementia. REVUE NEUROLOGIQUE. 1998 SEP; 154: S50-S64	2	2	22	150
1808	7226 Vescovi AL, Snyder EY Establishment and properties of neural stem cell clones: Plasticity in vitro and in vivo BRAIN PATHOLOGY. 1999 JUL; 9 (3): 569-598	19	88	12	150
1809	7757 Jellinger KA Morphological substrates of mental dysfunction in Lewy body disease: an update ADVANCES IN DEMENTIA RESEARCH. 2000; : 185-212	0	0	37	150
1810	8885 Doble A, Kennel P Animal models of amyotrophic lateral sclerosis AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS. 2000 DEC; 1 (5): 301-312	5	12	21	150
#	Date / Author / Journal	LCS	GCS	LCR	CR
1811	9387 Orth M, Schapira AHV Mitochondria and degenerative disorders AMERICAN JOURNAL OF MEDICAL GENETICS. 2001 SPR; 106 (1): 27-36	16	124	13	150
1812	9637 Neet KE, Campenot RB Receptor binding, internalization, and retrograde transport of neurotrophic factors CELLULAR AND MOLECULAR LIFE SCIENCES. 2001 JUL; 58 (8): 1021-1035	7	73	19	150
1813	10208 Ingelsson M, Hyman BT Disordered proteins in dementia ANNALS OF MEDICINE. 2002; 34 (4): 259-271	6	8	54	150
1814	10475 Kozlovsky N, Belmaker RH, Agam G GSK-3 and the neurodevelopmental hypothesis of schizophrenia EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2002 FEB; 12 (1): 13-25	9	64	24	150
1815	12649 Fam SS, Morrow JD The isoprostanes: Unique products of arachidonic acid oxidation - A review CURRENT MEDICINAL CHEMISTRY. 2003 SEP; 10 (17): 1723-1740	5	73	12	150
1816	14149 Michell AW, Lewis SJG, Foltynie T, Barker RA Biomarkers and Parkinson's disease BRAIN. 2004 AUG; 127: 1693-1705	21	52	18	150
1817	15556 Armstrong RA, Lantos PL, Cairns NJ Overlap between neurodegenerative disorders NEUROPATHOLOGY. 2005 JUN; 25 (2): 111-124	8	22	46	150
1818	15638 Bodey B, Siegel SE, Kaiser HE Immunocytochemical detection of members of the caspase cascade of apoptosis in childhood medulloblastomas IN VIVO. 2005 JUL-AUG; 19 (4): 749-760	0	0	4	150
1819	16296 Shobab LA, Hsiung GYR, Feldman HH Cholesterol in Alzheimer's disease LANCET NEUROLOGY. 2005 DEC; 4 (12): 841-852	14	105	9	150
1820	17837 Drachman DA Aging of the brain, entropy, and Alzheimer disease NEUROLOGY. 2006 OCT 24; 67 (8): 1340-1352	5	36	12	150
#	Date / Author / Journal	LCS	GCS	LCR	CR
1821	18016 Migeotte I, Communi D, Parmentier M Formyl peptide receptors: A promiscuous subfamily of G protein-coupled receptors controlling immune responses CYTOKINE & GROWTH FACTOR REVIEWS. 2006 DEC; 17 (6): 501-519	0	63	1	150
1822	18200 Thompson PM, Hayashi KM, Dutton RA, Chiang MC, Leow AD, et al. Tracking Alzheimer's disease IMAGING AND THE AGING BRAIN. 2007; 1097: 183-214	13	42	8	150
1823	19413 Geschwind MD, Haman A, Miller BL Rapidly progressive dementia NEUROLOGIC CLINICS. 2007 AUG; 25 (3): 783-+	2	9	11	150
1824	19700 Wakabayashi K, Tanji K, Mori F, Takahashi H The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of alpha-synuclein aggregates NEUROPATHOLOGY. 2007 OCT; 27 (5): 494-506	30	44	91	150
1825	20838 Newman MB, Bakay RAE Therapeutic Potentials of human embryonic stem cells in Parkinson's disease NEUROTHERAPEUTICS. 2008 APR; 5 (2): 237-251	3	14	15	150
1826	21591 Atanasova B, Graux J, El Hage W, Hommet C, Camus V, et al. Olfaction: A potential cognitive marker of psychiatric disorders NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2008 SEP; 32 (7): 1315-1325	3	12	15	150
1827	22390 Nelson PT, Braak H, Markesbery WR Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 JAN; 68 (1): 1-14	16	35	39	150
1828	23180 Diederich NJ, Fenelon G, Stebbins G, Goetz CG Hallucinations in Parkinson disease NATURE REVIEWS NEUROLOGY. 2009 JUN; 5 (6): 331-342	3	14	12	150
1829	24586 Lindvall O, Kokaia Z Stem cells in human neurodegenerative disorders - time for clinical translation? JOURNAL OF CLINICAL INVESTIGATION. 2010 JAN; 120 (1): 29-40	1	22	29	150
1830	604 NAKANO K, KOHNO M, HASEGAWA Y, TOKUSHIGE A CORTICAL AND BRAIN-STEM AFFERENTS TO THE VENTRAL THALAMIC NUCLEI OF THE CAT DEMONSTRATED BY RETROGRADE AXONAL-TRANSPORT OF HORSERADISH- PEROXIDASE JOURNAL OF COMPARATIVE NEUROLOGY. 1985; 231 (1): 102-120	2	49	13	149
#	Date / Author / Journal	LCS	GCS	LCR	CR
1831	6652 Kisby GE, Kabel H, Hugon J, Spencer P Damage and repair of nerve cell DNA in toxic stress DRUG METABOLISM REVIEWS. 1999; 31 (3): 589-618	0	27	4	149
1832	9341 Siyanova EY, Mirkin SM Expansion of trinucleotide repeats MOLECULAR BIOLOGY. 2001 MAR-APR; 35 (2): 168-182	1	5	9	149
1833	9597 Kochanek PM, Clark RSB, Ruppel RA, Dixon CE Cerebral resuscitation after traumatic brain injury and cardiopulmonary arrest in infants and children in the new millennium PEDIATRIC CLINICS OF NORTH AMERICA. 2001 JUN; 48 (3): 661-+	2	11	14	149
1834	9760 Mark MH Lumping and splitting the Parkinson plus syndromes - Dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degeneration NEUROLOGIC CLINICS. 2001 AUG; 19 (3): 607-+	3	18	31	149
1835	10181 Sekhon LHS, Fehlings MG Epidemiology, demographics, and pathophysiology of acute spinal cord injury SPINE. 2001 DEC 15; 26 (24): S2-S12	3	153	6	149
1836	10682 Cartegni L, Chew SL, Krainer AR Listening to silence and understanding nonsense: Exonic mutations that affect splicing NATURE REVIEWS GENETICS. 2002 APR; 3 (4): 285-298	23	891	5	149
1837	11541 O'Shea PJ, Williams GR Insight into the physiological actions of thyroid hormone receptors from genetically modified mice JOURNAL OF ENDOCRINOLOGY. 2002 DEC; 175 (3): 553-570	0	80	3	149
1838	12157 Watase K, Zoghbi HY Modelling brain diseases in mice: The challenges of design and analysis NATURE REVIEWS GENETICS. 2003 APR; 4 (4): 296-307	5	42	14	149
1839	14405 Bazan E, Alonso FJM, Redondo C, Lopez-Toledano MA, Alfaro JM, et al. In vitro and in vivo characterization of neural stem cells HISTOLOGY AND HISTOPATHOLOGY. 2004 OCT; 19 (4): 1261-1275	3	16	27	149
1840	18275 Sulejczak D, Skup M Neurodegeneration in experimental stroke - involvement of apoptosis- regulating proteins NEUROLOGIA I NEUROCHIRURGIA POLSKA. 2007; 41 (6): 533-547	0	0	14	149
#	Date / Author / Journal	LCS	GCS	LCR	CR
1841	19811 Lu KP, Zhou XZ The prolyl isomerase PIN 1: a pivotal new twist in phosphorylation signalling and disease NATURE REVIEWS MOLECULAR CELL BIOLOGY. 2007 NOV; 8 (11): 904-916	8	85	24	149
1842	19904 Daskalakis ZJ, Fitzgerald PB, Christensen BK The role of cortical inhibition in the pathophysiology and treatment of schizophrenia BRAIN RESEARCH REVIEWS. 2007 DEC; 56 (2): 427-442	0	21	7	149
1843	22113 Lu BW, Vogel H Drosophila Models of Neurodegenerative Diseases ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE. 2009; 4: 315-342	9	19	77	149
1844	22260 Sonntag KC, Simunovic F, Sanchez-Pernaute R Stem Cells and Cell Replacement Therapy for Parkinson's Disease JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2009; (73): 287-299	0	0	30	149
1845	22368 Soto C, Martin Z Therapeutic strategies against protein misfolding in neurodegenerative diseases EXPERT OPINION ON DRUG DISCOVERY. 2009 JAN; 4 (1): 71-84	1	3	25	149
1846	22818 Jelic V, Kowalski J Evidence-Based Evaluation of Diagnostic Accuracy of Resting EEG in Dementia and Mild Cognitive Impairment CLINICAL EEG AND NEUROSCIENCE. 2009 APR; 40 (2): 129-142	0	4	5	149
1847	22955 Liu YP, Lang BT, Baskaya MK, Dempsey RJ, Vemuganti R The potential of neural stem cells to repair stroke-induced brain damage ACTA NEUROPATHOLOGICA. 2009 MAY; 117 (5): 469-480	1	12	14	149
1848	22956 Kriz J, Lalancette-Hebert M Inflammation, plasticity and real-time imaging after cerebral ischemia ACTA NEUROPATHOLOGICA. 2009 MAY; 117 (5): 497-509	0	13	9	149
1849	23597 Lehman NL The ubiquitin proteasome system in neuropathology ACTA NEUROPATHOLOGICA. 2009 SEP; 118 (3): 329-347	3	14	25	149
1850	23819 Hedlund E, Perlmann T Neuronal cell replacement in Parkinson's disease JOURNAL OF INTERNAL MEDICINE. 2009 OCT; 266 (4): 358-371	3	8	37	149
#	Date / Author / Journal	LCS	GCS	LCR	CR
1851	25278 Shi M, Huber BR, Zhang J Biomarkers for Cognitive Impairment in Parkinson Disease BRAIN PATHOLOGY. 2010 MAY; 20 (3): 660-671	0	0	66	149
1852	25491 Su B, Wang XL, Bonda D, Perry G, Smith M, et al. Abnormal Mitochondrial Dynamics-A Novel Therapeutic Target for Alzheimer's Disease? MOLECULAR NEUROBIOLOGY. 2010 JUN; 41 (2-3): 87-96	0	1	15	149
1853	26123 Hayashi-Takagi A, Sawa A Disturbed synaptic connectivity in schizophrenia: Convergence of genetic risk factors during neurodevelopment BRAIN RESEARCH BULLETIN. 2010 SEP 30; 83 (3-4): 140-146	1	1	14	149
1854	26546 Whittington RA, Papon MA, Chouinard-Decorte F, Planel E Hypothermia and Alzheimer's Disease Neuropathogenic Pathways CURRENT ALZHEIMER RESEARCH. 2010 DEC; 7 (8): 717-725	1	1	46	149
1855	2110 MCLACHLAN DRC, KRUCK TP, LUKIW WJ, KRISHNAN SS WOULD DECREASED ALUMINUM INGESTION REDUCE THE INCIDENCE OF ALZHEIMERS- DISEASE CANADIAN MEDICAL ASSOCIATION JOURNAL. 1991 OCT 1; 145 (7): 793-804	14	81	3	148
1856	3403 CORIA F, RUBIO I, BAYON C ALZHEIMERS-DISEASE, BETA-AMYLOIDOSIS, AND AGING REVIEWS IN THE NEUROSCIENCES. 1994 OCT-DEC; 5 (4): 275-292	3	18	12	148
1857	3825 MEHLER MF, MARMUR R, GROSS R, MABIE PC, ZANG ZY, et al. CYTOKINES REGULATE THE CELLULAR PHENOTYPE OF DEVELOPING NEURAL LINEAGE SPECIES INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE. 1995 JUN-JUL; 13 (3-4): 213-240	6	47	3	148
1858	7217 Goedert M Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B- BIOLOGICAL SCIENCES. 1999 JUN 29; 354 (1386): 1101-1118	80	92	90	148
1859	8703 Mansergh FC, Wride MA, Rancourt DE Neurons from stem cells: Implications for understanding nervous system development and repair BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE. 2000 OCT; 78 (5): 613-628	0	13	8	148
1860	8782 Kam PCA, Ferch NI Apoptosis: mechanisms and clinical implications ANAESTHESIA. 2000 NOV; 55 (11): 1081-1093	2	59	2	148
#	Date / Author / Journal	LCS	GCS	LCR	CR
1861	8981 Rice DS, Curran T Role of the Reelin signaling pathway in central nervous system development ANNUAL REVIEW OF NEUROSCIENCE. 2001; 24: 1005-1039	12	317	9	148
1862	10321 Fernyhough P, Schmidt RE Neurofilaments in diabetic neuropathy NEUROBIOLOGY OF DIABETIC NEUROPATHY. 2002; 50: 115-144	0	11	41	148
1863	11373 Bounias M, Purdey M Transmissible spongiform encephalopathies: a family of etiologically complex diseases - a review SCIENCE OF THE TOTAL ENVIRONMENT. 2002 OCT 7; 297 (1-3): 1-19	0	11	10	148
1864	11866 Soto C Unfolding the role of protein misfolding in neurodegenerative diseases NATURE REVIEWS NEUROSCIENCE. 2003 JAN; 4 (1): 49-60	71	257	31	148
1865	11920 Richter-Landsberg C, Goldbaum O Stress proteins in neural cells: functional roles in health and disease CELLULAR AND MOLECULAR LIFE SCIENCES. 2003 FEB; 60 (2): 337-349	17	47	21	148
1866	14531 Ogden CA, Rich ME, Schork NJ, Paulus MP, Geyer MA, et al. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach MOLECULAR PSYCHIATRY. 2004 NOV; 9 (11): 1007-1029	5	90	11	148
1867	14955 Ko LW, DeTure M, Sahara N, Chihab R, Vega IE, et al. Recent advances in experimental modeling of the assembly of tau filaments BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 125-139	5	9	103	148
1868	17080 Bayir H, Fadeel B, Palladino MJ, Witasp E, Kurnikov IV, et al. Apoptotic interactions of cyctochrome c: Redox flirting with anionic phospholipids within and outside of mitochondria BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS. 2006 MAY-JUN; 1757 (5-6): 648-659	2	56	6	148
1869	17189 Obeid R, Herrmann W Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia FEBS LETTERS. 2006 MAY 29; 580 (13): 2994-3005	6	67	9	148
1870	17382 Nunomura A, Castellani RJ, Zhu XW, Moreira PI, Perry G, et al. Involvement of oxidative stress in Alzheimer disease JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2006 JUL; 65 (7): 631-641	28	111	32	148
#	Date / Author / Journal	LCS	GCS	LCR	CR
1871	17469 Gotz J, Ittner LM, Kins S Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease? JOURNAL OF NEUROCHEMISTRY. 2006 AUG; 98 (4): 993-1006	23	37	60	148
1872	18027 Dutta AK, Le WD Existing dopaminergic therapies for Parkinson's disease EXPERT OPINION ON THERAPEUTIC PATENTS. 2006 DEC; 16 (12): 1613-1625	1	5	20	148
1873	18430 Gallego MG, Barreiro AF Gene therapy for Parkinson's disease NEUROLOGIA. 2007 JAN-FEB; 22 (1): 27-38	0	0	10	148
1874	19384 Mitelman SA, Buchsbaum MS Very poor outcome schizophrenia: Clinical and neuroimaging aspects INTERNATIONAL REVIEW OF PSYCHIATRY. 2007 AUG; 19 (4): 347-359	0	1	23	148
1875	22654 Locatelli F, Bersano A, Ballabio E, Lanfranconi S, Papadimitriou D, et al. Stem cell therapy in stroke CELLULAR AND MOLECULAR LIFE SCIENCES. 2009 MAR; 66 (5): 757-772	5	12	18	148
1876	24552 Gibson GE, Starkov A, Blass JP, Ratan RR, Beal MF Cause and consequence: Mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 JAN; 1802 (1): 122-134	5	13	17	148
1877	1777 KIVELA T, TARKKANEN A THE MERKEL CELL AND ASSOCIATED NEOPLASMS IN THE EYELIDS AND PERIOCULAR REGION SURVEY OF OPHTHALMOLOGY. 1990 NOV-DEC; 35 (3): 171-187	4	51	11	147
1878	2601 LUDIN B, MATUS A THE NEURONAL CYTOSKELETON AND ITS ROLE IN AXONAL AND DENDRITIC PLASTICITY HIPPOCAMPUS. 1993; 3: 61-71	12	34	15	147
1879	4925 Weber T, Aguzzi A The spectrum of transmissible spongiform encephalopathies INTERVIROLOGY. 1997 MAR-JUN; 40 (2-3): 198-212	1	16	5	147
1880	5357 Larner AJ, Rossor MN Alzheimer's disease: Towards therapeutic manipulation of the amyloid precursor protein and amyloid beta-peptides EXPERT OPINION ON THERAPEUTIC PATENTS. 1997 OCT; 7 (10): 1115-1127	2	9	16	147
#	Date / Author / Journal	LCS	GCS	LCR	CR
1881	6353 Raeber AJ, Brandner S, Klein MA, Benninger Y, Musahl C, et al. Transgenic and knockout mice in research on prion diseases BRAIN PATHOLOGY. 1998 OCT; 8 (4): 715-733	3	35	6	147
1882	6658 Henn FA, Braus DF Structural neuroimaging in schizophrenia - An integrative view of neuromorphology EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 1999; 249: 48-56	2	23	10	147
1883	6743 Cookson MR, Shaw PJ Oxidative stress and motor neurone disease BRAIN PATHOLOGY. 1999 JAN; 9 (1): 165-186	31	119	34	147
1884	8626 Stoll G, Jander S, Siebler M, Schroeter M Immunological aspects of ischaemic stroke - Therapeutic implications CNS DRUGS. 2000 SEP; 14 (3): 213-228	0	0	2	147
1885	8985 Bjarkam CR, Sorensen JC, Sunde NA, Geneser FA, Ostergaard K New strategies for the treatment of Parkinson's disease hold considerable promise for the future management of neurodegenerative disorders BIOGERONTOLOGY. 2001; 2 (3): 193-207	3	15	4	147
1886	9948 Frame S, Cohen P GSK3 takes centre stage more than 20 years after its discovery BIOCHEMICAL JOURNAL. 2001 OCT 1; 359: 1-16	16	609	10	147
1887	12069 Linazasoro G Steam cells: solution to the problem of transplants in Parkinson's disease? NEUROLOGIA. 2003 MAR; 18 (2): 74-100	0	3	28	147
1888	12644 Atwood CS, Bowen RL, Smith MA, Perry G Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supply BRAIN RESEARCH REVIEWS. 2003 SEP; 43 (1): 164-178	1	12	19	147
1889	13837 Schols L, Bauer P, Schmidt T, Schulte T, Riess O Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis LANCET NEUROLOGY. 2004 MAY; 3 (5): 291-304	28	224	29	147
1890	14960 Iqbal K, Alonso ADC, Chen S, Chohan MO, El-Akkad E, et al. Tau pathology in Alzheimer disease and other tauopathies BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 198-210	100	154	81	147
#	Date / Author / Journal	LCS	GCS	LCR	CR
1891	15166 Landis GN, Tower J Superoxide dismutase evolution and life span regulation MECHANISMS OF AGEING AND DEVELOPMENT. 2005 MAR; 126 (3): 365-379	2	99	3	147
1892	15868 Rehn AE, Rees SM Investigating the neurodevelopmental hypothesis of schizophrenia CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 2005 SEP; 32 (9): 687-696	0	22	24	147
1893	15870 Ross CA, Margolis RL Neurogenetics: insights into degenerative diseases and approaches to schizophrenia CLINICAL NEUROSCIENCE RESEARCH. 2005 SEP; 5 (1): 3-14	1	6	43	147
1894	16511 Hinault MP, Ben-Zvi A, Goloubinoff P Chaperones and proteases - Cellular fold-controlling factors of proteins in Neurodegenerative diseases and aging JOURNAL OF MOLECULAR NEUROSCIENCE. 2006; 30 (3): 249-265	8	31	29	147
1895	17337 Lang K, Entschladen F, Weidt C, Zaenker KS Tumor immune escape mechanisms: impact of the neuroendocrine system CANCER IMMUNOLOGY IMMUNOTHERAPY. 2006 JUL; 55 (7): 749-760	0	12	1	147
1896	18007 Sontag JM, Sontag E Regulation of cell adhesion by PP2A and SV40 small tumor antigen: An important link to cell transformation CELLULAR AND MOLECULAR LIFE SCIENCES. 2006 DEC; 63 (24): 2979-2991	0	15	10	147
1897	18967 Bedlack RS, Traynor BJ, Cudkowicz ME Emerging disease-modifying therapies for the treatment of motor neuron diseasd/amyotropic lateral sclerosis EXPERT OPINION ON EMERGING DRUGS. 2007 MAY; 12 (2): 229-252	0	5	19	147
1898	21423 Fujimoto T, Ohsaki Y, Cheng J, Suzuki M, Shinohara Y Lipid droplets: a classic organelle with new outfits HISTOCHEMISTRY AND CELL BIOLOGY. 2008 AUG; 130 (2): 263-279	0	48	5	147
1899	24134 Giordano C, Albani D, Gloria A, Tunesi M, Batelli S, et al. Multidisciplinary perspectives for Alzheimer's and Parkinson's diseases: hydrogels for protein delivery and cell-based drug delivery as therapeutic strategies INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS. 2009 DEC; 32 (12): 836-850	0	1	17	147
1900	24345 Jicha GA, Carr SA Conceptual Evolution in Alzheimer's Disease: Implications for Understanding the Clinical Phenotype of Progressive Neurodegenerative Disease JOURNAL OF ALZHEIMERS DISEASE. 2010; 19 (1): 253-272	0	0	30	147

Date / Author / Journal

LCS

GCS

LCR

1801

23858 Crews L, Tsigelny I, Hashimoto M, Masliah E

Role of Synucleins in Alzheimer's Disease

NEUROTOXICITY RESEARCH. 2009 OCT; 16 (3): 306-317

151

1802

24209 Bousman CA, Glatt SJ, Everall IP, Tsuang MT

Genetic Association Studies of Methamphetamine Use Disorders: A Systematic Review and Synthesis

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS. 2009 DEC 5; 150B (8): 1025-1049

151

1803

25516 Johansen KK, White LR, Sando SB, Aasly JO

Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies

PARKINSONISM & RELATED DISORDERS. 2010 JUN; 16 (5): 307-315

151

1804

26285 Greenwald J, Riek R

Biology of Amyloid: Structure, Function, and Regulation

STRUCTURE. 2010 OCT 13; 18 (10): 1244-1260

151

1805

26559 Antonelli F, Ray N, Strafella AP

Imaging cognitive and behavioral symptoms in Parkinson's disease

EXPERT REVIEW OF NEUROTHERAPEUTICS. 2010 DEC; 10 (12): 1827-1838

151

1806

4952 Plassman BL, Breitner JCS

The genetics of dementia in late life

PSYCHIATRIC CLINICS OF NORTH AMERICA. 1997 MAR; 20 (1): 59-&

150

1807

6313 Hauw JJ, Seilhean D, Colle MA, Hogenhuys J, Duyckaerts G

Neuropathological markers of degenerative dementia.

REVUE NEUROLOGIQUE. 1998 SEP; 154: S50-S64

150

1808

7226 Vescovi AL, Snyder EY

Establishment and properties of neural stem cell clones: Plasticity in vitro and in vivo

BRAIN PATHOLOGY. 1999 JUL; 9 (3): 569-598

150

1809

7757 Jellinger KA

Morphological substrates of mental dysfunction in Lewy body disease: an update

ADVANCES IN DEMENTIA RESEARCH. 2000; : 185-212

150

1810

8885 Doble A, Kennel P

Animal models of amyotrophic lateral sclerosis

AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS. 2000 DEC; 1 (5): 301-312

150

Date / Author / Journal

LCS

GCS

LCR

1811

9387 Orth M, Schapira AHV

Mitochondria and degenerative disorders

AMERICAN JOURNAL OF MEDICAL GENETICS. 2001 SPR; 106 (1): 27-36

124

150

1812

9637 Neet KE, Campenot RB

Receptor binding, internalization, and retrograde transport of neurotrophic factors

CELLULAR AND MOLECULAR LIFE SCIENCES. 2001 JUL; 58 (8): 1021-1035

150

1813

10208 Ingelsson M, Hyman BT

Disordered proteins in dementia

ANNALS OF MEDICINE. 2002; 34 (4): 259-271

150

1814

10475 Kozlovsky N, Belmaker RH, Agam G

GSK-3 and the neurodevelopmental hypothesis of schizophrenia

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2002 FEB; 12 (1): 13-25

150

1815

12649 Fam SS, Morrow JD

The isoprostanes: Unique products of arachidonic acid oxidation - A review

CURRENT MEDICINAL CHEMISTRY. 2003 SEP; 10 (17): 1723-1740

150

1816

14149 Michell AW, Lewis SJG, Foltynie T, Barker RA

Biomarkers and Parkinson's disease

BRAIN. 2004 AUG; 127: 1693-1705

150

1817

15556 Armstrong RA, Lantos PL, Cairns NJ

Overlap between neurodegenerative disorders

NEUROPATHOLOGY. 2005 JUN; 25 (2): 111-124

150

1818

15638 Bodey B, Siegel SE, Kaiser HE

Immunocytochemical detection of members of the caspase cascade of apoptosis in childhood medulloblastomas

IN VIVO. 2005 JUL-AUG; 19 (4): 749-760

150

1819

16296 Shobab LA, Hsiung GYR, Feldman HH

Cholesterol in Alzheimer's disease

LANCET NEUROLOGY. 2005 DEC; 4 (12): 841-852

105

150

1820

17837 Drachman DA

Aging of the brain, entropy, and Alzheimer disease

NEUROLOGY. 2006 OCT 24; 67 (8): 1340-1352

150

Date / Author / Journal

LCS

GCS

LCR

1821

18016 Migeotte I, Communi D, Parmentier M

Formyl peptide receptors: A promiscuous subfamily of G protein-coupled receptors controlling immune responses

CYTOKINE & GROWTH FACTOR REVIEWS. 2006 DEC; 17 (6): 501-519

150

1822

18200 Thompson PM, Hayashi KM, Dutton RA, Chiang MC, Leow AD, et al.

Tracking Alzheimer's disease

IMAGING AND THE AGING BRAIN. 2007; 1097: 183-214

150

1823

19413 Geschwind MD, Haman A, Miller BL

Rapidly progressive dementia

NEUROLOGIC CLINICS. 2007 AUG; 25 (3): 783-+

150

1824

19700 Wakabayashi K, Tanji K, Mori F, Takahashi H

The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of alpha-synuclein aggregates

NEUROPATHOLOGY. 2007 OCT; 27 (5): 494-506

150

1825

20838 Newman MB, Bakay RAE

Therapeutic Potentials of human embryonic stem cells in Parkinson's disease

NEUROTHERAPEUTICS. 2008 APR; 5 (2): 237-251

150

1826

21591 Atanasova B, Graux J, El Hage W, Hommet C, Camus V, et al.

Olfaction: A potential cognitive marker of psychiatric disorders

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2008 SEP; 32 (7): 1315-1325

150

1827

22390 Nelson PT, Braak H, Markesbery WR

Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 JAN; 68 (1): 1-14

150

1828

23180 Diederich NJ, Fenelon G, Stebbins G, Goetz CG

Hallucinations in Parkinson disease

NATURE REVIEWS NEUROLOGY. 2009 JUN; 5 (6): 331-342

150

1829

24586 Lindvall O, Kokaia Z

Stem cells in human neurodegenerative disorders - time for clinical translation?

JOURNAL OF CLINICAL INVESTIGATION. 2010 JAN; 120 (1): 29-40

150

1830

604 NAKANO K, KOHNO M, HASEGAWA Y, TOKUSHIGE A

CORTICAL AND BRAIN-STEM AFFERENTS TO THE VENTRAL THALAMIC NUCLEI OF THE CAT DEMONSTRATED BY RETROGRADE AXONAL-TRANSPORT OF HORSERADISH- PEROXIDASE

JOURNAL OF COMPARATIVE NEUROLOGY. 1985; 231 (1): 102-120

149

Date / Author / Journal

LCS

GCS

LCR

1831

6652 Kisby GE, Kabel H, Hugon J, Spencer P

Damage and repair of nerve cell DNA in toxic stress

DRUG METABOLISM REVIEWS. 1999; 31 (3): 589-618

149

1832

9341 Siyanova EY, Mirkin SM

Expansion of trinucleotide repeats

MOLECULAR BIOLOGY. 2001 MAR-APR; 35 (2): 168-182

149

1833

9597 Kochanek PM, Clark RSB, Ruppel RA, Dixon CE

Cerebral resuscitation after traumatic brain injury and cardiopulmonary arrest in infants and children in the new millennium

PEDIATRIC CLINICS OF NORTH AMERICA. 2001 JUN; 48 (3): 661-+

149

1834

9760 Mark MH

Lumping and splitting the Parkinson plus syndromes - Dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degeneration

NEUROLOGIC CLINICS. 2001 AUG; 19 (3): 607-+

149

1835

10181 Sekhon LHS, Fehlings MG

Epidemiology, demographics, and pathophysiology of acute spinal cord injury

SPINE. 2001 DEC 15; 26 (24): S2-S12

153

149

1836

10682 Cartegni L, Chew SL, Krainer AR

Listening to silence and understanding nonsense: Exonic mutations that affect splicing

NATURE REVIEWS GENETICS. 2002 APR; 3 (4): 285-298

891

149

1837

11541 O'Shea PJ, Williams GR

Insight into the physiological actions of thyroid hormone receptors from genetically modified mice

JOURNAL OF ENDOCRINOLOGY. 2002 DEC; 175 (3): 553-570

149

1838

12157 Watase K, Zoghbi HY

Modelling brain diseases in mice: The challenges of design and analysis

NATURE REVIEWS GENETICS. 2003 APR; 4 (4): 296-307

149

1839

14405 Bazan E, Alonso FJM, Redondo C, Lopez-Toledano MA, Alfaro JM, et al.

In vitro and in vivo characterization of neural stem cells

HISTOLOGY AND HISTOPATHOLOGY. 2004 OCT; 19 (4): 1261-1275

149

1840

18275 Sulejczak D, Skup M

Neurodegeneration in experimental stroke - involvement of apoptosis- regulating proteins

NEUROLOGIA I NEUROCHIRURGIA POLSKA. 2007; 41 (6): 533-547

149

Date / Author / Journal

1841

The prolyl isomerase PIN 1: a pivotal new twist in phosphorylation signalling and disease

NATURE REVIEWS MOLECULAR CELL BIOLOGY. 2007 NOV; 8 (11): 904-916

149

1842

19904 Daskalakis ZJ, Fitzgerald PB, Christensen BK

The role of cortical inhibition in the pathophysiology and treatment of schizophrenia

BRAIN RESEARCH REVIEWS. 2007 DEC; 56 (2): 427-442

149

1843

22113 Lu BW, Vogel H

Drosophila Models of Neurodegenerative Diseases

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE. 2009; 4: 315-342

149

1844

22260 Sonntag KC, Simunovic F, Sanchez-Pernaute R

Stem Cells and Cell Replacement Therapy for Parkinson's Disease

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2009; (73): 287-299

149

1845

22368 Soto C, Martin Z

Therapeutic strategies against protein misfolding in neurodegenerative diseases

EXPERT OPINION ON DRUG DISCOVERY. 2009 JAN; 4 (1): 71-84

149

1846

22818 Jelic V, Kowalski J

Evidence-Based Evaluation of Diagnostic Accuracy of Resting EEG in Dementia and Mild Cognitive Impairment

CLINICAL EEG AND NEUROSCIENCE. 2009 APR; 40 (2): 129-142

149

1847

22955 Liu YP, Lang BT, Baskaya MK, Dempsey RJ, Vemuganti R

The potential of neural stem cells to repair stroke-induced brain damage

ACTA NEUROPATHOLOGICA. 2009 MAY; 117 (5): 469-480

149

1848

22956 Kriz J, Lalancette-Hebert M

Inflammation, plasticity and real-time imaging after cerebral ischemia

ACTA NEUROPATHOLOGICA. 2009 MAY; 117 (5): 497-509

149

1849

23597 Lehman NL

The ubiquitin proteasome system in neuropathology

ACTA NEUROPATHOLOGICA. 2009 SEP; 118 (3): 329-347

149

1850

23819 Hedlund E, Perlmann T

Neuronal cell replacement in Parkinson's disease

JOURNAL OF INTERNAL MEDICINE. 2009 OCT; 266 (4): 358-371

149

Date / Author / Journal

LCS

GCS

LCR

1851

25278 Shi M, Huber BR, Zhang J

Biomarkers for Cognitive Impairment in Parkinson Disease

BRAIN PATHOLOGY. 2010 MAY; 20 (3): 660-671

149

1852

25491 Su B, Wang XL, Bonda D, Perry G, Smith M, et al.

Abnormal Mitochondrial Dynamics-A Novel Therapeutic Target for Alzheimer's Disease?

MOLECULAR NEUROBIOLOGY. 2010 JUN; 41 (2-3): 87-96

149

1853

26123 Hayashi-Takagi A, Sawa A

Disturbed synaptic connectivity in schizophrenia: Convergence of genetic risk factors during neurodevelopment

BRAIN RESEARCH BULLETIN. 2010 SEP 30; 83 (3-4): 140-146

149

1854

26546 Whittington RA, Papon MA, Chouinard-Decorte F, Planel E

Hypothermia and Alzheimer's Disease Neuropathogenic Pathways

CURRENT ALZHEIMER RESEARCH. 2010 DEC; 7 (8): 717-725

149

1855

2110 MCLACHLAN DRC, KRUCK TP, LUKIW WJ, KRISHNAN SS

WOULD DECREASED ALUMINUM INGESTION REDUCE THE INCIDENCE OF ALZHEIMERS- DISEASE

CANADIAN MEDICAL ASSOCIATION JOURNAL. 1991 OCT 1; 145 (7): 793-804

148

1856

3403 CORIA F, RUBIO I, BAYON C

ALZHEIMERS-DISEASE, BETA-AMYLOIDOSIS, AND AGING

REVIEWS IN THE NEUROSCIENCES. 1994 OCT-DEC; 5 (4): 275-292

148

1857

3825 MEHLER MF, MARMUR R, GROSS R, MABIE PC, ZANG ZY, et al.

CYTOKINES REGULATE THE CELLULAR PHENOTYPE OF DEVELOPING NEURAL LINEAGE SPECIES

INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE. 1995 JUN-JUL; 13 (3-4): 213-240

148

1858

7217 Goedert M

Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B- BIOLOGICAL SCIENCES. 1999 JUN 29; 354 (1386): 1101-1118

148

1859

8703 Mansergh FC, Wride MA, Rancourt DE

Neurons from stem cells: Implications for understanding nervous system development and repair

BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE. 2000 OCT; 78 (5): 613-628

148

1860

8782 Kam PCA, Ferch NI

Apoptosis: mechanisms and clinical implications

ANAESTHESIA. 2000 NOV; 55 (11): 1081-1093

148

Date / Author / Journal

LCS

GCS

LCR

1861

8981 Rice DS, Curran T

Role of the Reelin signaling pathway in central nervous system development

ANNUAL REVIEW OF NEUROSCIENCE. 2001; 24: 1005-1039

317

148

1862

10321 Fernyhough P, Schmidt RE

Neurofilaments in diabetic neuropathy

NEUROBIOLOGY OF DIABETIC NEUROPATHY. 2002; 50: 115-144

148

1863

11373 Bounias M, Purdey M

Transmissible spongiform encephalopathies: a family of etiologically complex diseases - a review

SCIENCE OF THE TOTAL ENVIRONMENT. 2002 OCT 7; 297 (1-3): 1-19

148

1864

11866 Soto C

Unfolding the role of protein misfolding in neurodegenerative diseases

NATURE REVIEWS NEUROSCIENCE. 2003 JAN; 4 (1): 49-60

257

148

1865

11920 Richter-Landsberg C, Goldbaum O

Stress proteins in neural cells: functional roles in health and disease

CELLULAR AND MOLECULAR LIFE SCIENCES. 2003 FEB; 60 (2): 337-349

148

1866

14531 Ogden CA, Rich ME, Schork NJ, Paulus MP, Geyer MA, et al.

Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach

MOLECULAR PSYCHIATRY. 2004 NOV; 9 (11): 1007-1029

148

1867

14955 Ko LW, DeTure M, Sahara N, Chihab R, Vega IE, et al.

Recent advances in experimental modeling of the assembly of tau filaments

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 125-139

103

148

1868

17080 Bayir H, Fadeel B, Palladino MJ, Witasp E, Kurnikov IV, et al.

Apoptotic interactions of cyctochrome c: Redox flirting with anionic phospholipids within and outside of mitochondria

BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS. 2006 MAY-JUN; 1757 (5-6): 648-659

148

1869

17189 Obeid R, Herrmann W

Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia

FEBS LETTERS. 2006 MAY 29; 580 (13): 2994-3005

148

1870

17382 Nunomura A, Castellani RJ, Zhu XW, Moreira PI, Perry G, et al.

Involvement of oxidative stress in Alzheimer disease

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2006 JUL; 65 (7): 631-641

111

148

Date / Author / Journal

LCS

GCS

LCR

1871

17469 Gotz J, Ittner LM, Kins S

Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?

JOURNAL OF NEUROCHEMISTRY. 2006 AUG; 98 (4): 993-1006

148

1872

18027 Dutta AK, Le WD

Existing dopaminergic therapies for Parkinson's disease

EXPERT OPINION ON THERAPEUTIC PATENTS. 2006 DEC; 16 (12): 1613-1625

148

1873

18430 Gallego MG, Barreiro AF

Gene therapy for Parkinson's disease

NEUROLOGIA. 2007 JAN-FEB; 22 (1): 27-38

148

1874

19384 Mitelman SA, Buchsbaum MS

Very poor outcome schizophrenia: Clinical and neuroimaging aspects

INTERNATIONAL REVIEW OF PSYCHIATRY. 2007 AUG; 19 (4): 347-359

148

1875

22654 Locatelli F, Bersano A, Ballabio E, Lanfranconi S, Papadimitriou D, et al.

Stem cell therapy in stroke

CELLULAR AND MOLECULAR LIFE SCIENCES. 2009 MAR; 66 (5): 757-772

148

1876

24552 Gibson GE, Starkov A, Blass JP, Ratan RR, Beal MF

Cause and consequence: Mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 JAN; 1802 (1): 122-134

148

1877

1777 KIVELA T, TARKKANEN A

THE MERKEL CELL AND ASSOCIATED NEOPLASMS IN THE EYELIDS AND PERIOCULAR REGION

SURVEY OF OPHTHALMOLOGY. 1990 NOV-DEC; 35 (3): 171-187

147

1878

2601 LUDIN B, MATUS A

THE NEURONAL CYTOSKELETON AND ITS ROLE IN AXONAL AND DENDRITIC PLASTICITY

HIPPOCAMPUS. 1993; 3: 61-71

147

1879

4925 Weber T, Aguzzi A

The spectrum of transmissible spongiform encephalopathies

INTERVIROLOGY. 1997 MAR-JUN; 40 (2-3): 198-212

147

1880

5357 Larner AJ, Rossor MN

Alzheimer's disease: Towards therapeutic manipulation of the amyloid precursor protein and amyloid beta-peptides

EXPERT OPINION ON THERAPEUTIC PATENTS. 1997 OCT; 7 (10): 1115-1127

147

Date / Author / Journal

LCS

GCS

LCR

1881

6353 Raeber AJ, Brandner S, Klein MA, Benninger Y, Musahl C, et al.

Transgenic and knockout mice in research on prion diseases

BRAIN PATHOLOGY. 1998 OCT; 8 (4): 715-733

147

1882

6658 Henn FA, Braus DF

Structural neuroimaging in schizophrenia - An integrative view of neuromorphology

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 1999; 249: 48-56

147

1883

6743 Cookson MR, Shaw PJ

Oxidative stress and motor neurone disease

BRAIN PATHOLOGY. 1999 JAN; 9 (1): 165-186

119

147

1884

8626 Stoll G, Jander S, Siebler M, Schroeter M

Immunological aspects of ischaemic stroke - Therapeutic implications

CNS DRUGS. 2000 SEP; 14 (3): 213-228

147

1885

8985 Bjarkam CR, Sorensen JC, Sunde NA, Geneser FA, Ostergaard K

New strategies for the treatment of Parkinson's disease hold considerable promise for the future management of neurodegenerative disorders

BIOGERONTOLOGY. 2001; 2 (3): 193-207

147

1886

9948 Frame S, Cohen P

GSK3 takes centre stage more than 20 years after its discovery

BIOCHEMICAL JOURNAL. 2001 OCT 1; 359: 1-16

609

147

1887

12069 Linazasoro G

Steam cells: solution to the problem of transplants in Parkinson's disease?

NEUROLOGIA. 2003 MAR; 18 (2): 74-100

147

1888

12644 Atwood CS, Bowen RL, Smith MA, Perry G

Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supply

BRAIN RESEARCH REVIEWS. 2003 SEP; 43 (1): 164-178

147

1889

13837 Schols L, Bauer P, Schmidt T, Schulte T, Riess O

Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis

LANCET NEUROLOGY. 2004 MAY; 3 (5): 291-304

224

147

1890

14960 Iqbal K, Alonso ADC, Chen S, Chohan MO, El-Akkad E, et al.

Tau pathology in Alzheimer disease and other tauopathies

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 198-210

100

154

147

Date / Author / Journal

LCS

GCS

LCR

1891

15166 Landis GN, Tower J

Superoxide dismutase evolution and life span regulation

MECHANISMS OF AGEING AND DEVELOPMENT. 2005 MAR; 126 (3): 365-379

147

1892

15868 Rehn AE, Rees SM

Investigating the neurodevelopmental hypothesis of schizophrenia

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 2005 SEP; 32 (9): 687-696

147

1893

15870 Ross CA, Margolis RL

Neurogenetics: insights into degenerative diseases and approaches to schizophrenia

CLINICAL NEUROSCIENCE RESEARCH. 2005 SEP; 5 (1): 3-14

147

1894

16511 Hinault MP, Ben-Zvi A, Goloubinoff P

Chaperones and proteases - Cellular fold-controlling factors of proteins in Neurodegenerative diseases and aging

JOURNAL OF MOLECULAR NEUROSCIENCE. 2006; 30 (3): 249-265

147

1895

17337 Lang K, Entschladen F, Weidt C, Zaenker KS

Tumor immune escape mechanisms: impact of the neuroendocrine system

CANCER IMMUNOLOGY IMMUNOTHERAPY. 2006 JUL; 55 (7): 749-760

147

1896

18007 Sontag JM, Sontag E

Regulation of cell adhesion by PP2A and SV40 small tumor antigen: An important link to cell transformation

CELLULAR AND MOLECULAR LIFE SCIENCES. 2006 DEC; 63 (24): 2979-2991

147

1897

18967 Bedlack RS, Traynor BJ, Cudkowicz ME

Emerging disease-modifying therapies for the treatment of motor neuron diseasd/amyotropic lateral sclerosis

EXPERT OPINION ON EMERGING DRUGS. 2007 MAY; 12 (2): 229-252

147

1898

21423 Fujimoto T, Ohsaki Y, Cheng J, Suzuki M, Shinohara Y

Lipid droplets: a classic organelle with new outfits

HISTOCHEMISTRY AND CELL BIOLOGY. 2008 AUG; 130 (2): 263-279

147

1899

24134 Giordano C, Albani D, Gloria A, Tunesi M, Batelli S, et al.

Multidisciplinary perspectives for Alzheimer's and Parkinson's diseases: hydrogels for protein delivery and cell-based drug delivery as therapeutic strategies

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS. 2009 DEC; 32 (12): 836-850

147

1900

24345 Jicha GA, Carr SA

Conceptual Evolution in Alzheimer's Disease: Implications for Understanding the Clinical Phenotype of Progressive Neurodegenerative Disease

JOURNAL OF ALZHEIMERS DISEASE. 2010; 19 (1): 253-272

147

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records